DBV Technologies Announces Financing of up to $306.9 Million ( €284.5 Million) to Advance Viaskin ® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approv

1 year ago 51

1. Homepage
2. Finance
3. DBV Technologies Announces Financing of up to $306.9 Million ( €284.5 Million) to Advance Viaskin ® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approv